Feasibility and Functionality of fPAM Imaging in Melanoma
- Conditions
- Melanoma
- Registration Number
- NCT00776945
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
Melanoma is a cutaneous malignancy that has the potential for local (skin) and regional (lymph node) recurrence. These recurrences may be difficult to detect in their earliest stages. We are attempting to use novel form of skin imaging that uses ultrasound combined with laser to identify these recurrences early, when they may be most amenable to treatment. This imaging will detect melanoma pigment below the surface of the skin and in the draining lymph nodes, as well as new blood vessel formation that occurs with these loco-regional metastases.
- Detailed Description
recruiting healthy individuals with pigmented lesions and individuals with melanoma and pigmented lesions
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 2
- Adult patients (> 18 yrs of age) with recently diagnosed or a history of, Stage I - III melanoma who are able to give informed consent.
- Patients with melanomas < 1mm.
- Pregnant females.
- Children and young adults < 18 yrs of age and patients who are unable to give informed consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method fPAM is a hybrid imaging technique that detects absorbed diffuse photons ultrasonically through the photoacoustic (PA) effect baseline Evaluate pigmented lesions for depth, width, total hemoglobin saturation, melanin distribution, and melanin concentration using fPAM in vivo and ex vivo
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Washington University School of Medicine
🇺🇸St. Louis, Missouri, United States
Washington University
🇺🇸Saint Louis, Missouri, United States